Overview

A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
Cidofovir could be an effective drug for the treatment of Anal Intraepithelial Neoplasia(AIN).
Phase:
N/A
Details
Lead Sponsor:
Fundacion SEIMC-GESIDA
Treatments:
Cidofovir